Evidence map›Paper›PMID 25068417›Full record

ArticleBone marrow transplantation2014

Advance care planning among hematopoietic cell transplant patients and bereaved caregivers.

E T Loggers, S Lee, K Chilson, A L Back, S Block, F R Loberiza

Open access · greenAbstract read
In one paragraph

Article in Bone marrow transplantation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Sequencing therapy in relapsed DLBCL.Hematology. American Society of Hematology. Education Program · 2022
    Article
  6. Article
  7. Observational
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

E T Loggers1] Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA [2] Group Health Research Institute, Group Health Co-operative, Seattle, WA, USA.
S Lee1] Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA [2] Medical Oncology, University of Washington, Seattle, WA, USA.
K ChilsonClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
A L BackMedical Oncology, University of Washington, Seattle, WA, USA.
S BlockDepartment of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA, USA.
F R LoberizaDivision of Oncology/Hematology, University of Nebraska Medical Center, Omaha, NE, USA.
Dana-Farber Cancer Institute · USFred Hutch Cancer Center · USUniversity of Nebraska Medical Center · USUniversity of Washington Medical Center · US

Funding

Enhancing Doctor-Patient CommunicationR01CA098486 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI LEE, STEPHANIE J · 2003 to 2006
$1.9M
NCI NIH HHS CA 098486NCI NIH HHS R01 CA098486
6 · The paper itself

Abstract

Younger, healthier patients contemplating high-risk (but potentially curative) hematopoietic cell transplants (HCT) may not consider advance care planning (ACP). We investigated the effect of pre transplant ACP in surviving HCT patients and bereaved caregivers using retrospective, audiotaped telephone surveys. Subjects were identified between 2001 and 2003 via databases at two high-volume HCT centers. Transcripts were coded by two investigators, with differences resolved by consensus. HCT survivors (n=18) were interviewed a median of 13 months after HCT for acute leukemia (7), lymphoma (5) or other (6); 50% had living wills, 72% had a formal proxy. Twelve (67%) had discussed mortality risk pre HCT with the medical team. Of those, 92% felt their hope and perception of the medical team's truthfulness was increased or unchanged (I/U) by the conversation, whereas all felt clinician commitment to transplant was I/U. Bereaved caregivers (n=11) were interviewed a median of 10 months post death (median 31 days post HCT, range 13-152). Nine (82%) had discussed mortality risk pre-HCT with the medical team; 7 (78%) felt hope was I/U, all felt clinician commitment to transplant and truthfulness was I/U, and most felt ACP reduced burden (67%). ACP discussions with patients and caregivers pre-HCT did not affect hope and supported confidence in medical teams.

Indexed as

AdultAdvance Care PlanningAgedCaregiversFemaleHematopoietic Stem Cell TransplantationHumansMaleMiddle AgedRetrospective StudiesSurvivorsTransplantation Conditioning

Identifiers

PMID25068417
PMCPMC4192015
OpenAlexW2078738547

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.